X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Clinical Trial Imaging Companies

This report lists the top Clinical Trial Imaging companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Clinical Trial Imaging industry.

Home Market Analysis Healthcare Research Healthcare IT Research Healthcare Provider IT Research Clinical IT Research Medical Image Analysis Research Clinical Trial Imaging Services Market Companies

Clinical Trial Imaging Top Companies

  1. Koninklijke Philips N.V

  2. Icon PLC

  3. WIRB-Copernicus Group

  4. Ixico PLC

  5. Navitas Clinical Research, Inc

*Disclaimer: Top companies sorted in no particular order

Clinical Trial Imaging Market Major Players

Clinical Trial Imaging Market Concentration

Clinical Trial Imaging Market Concentration

Clinical Trial Imaging Company List

                              • Clario

                              • Icon PLC

                              • Ixico PLC

                              • Koninklijke Philips N.V

                              • Medpace

                              • Navitas Clinical Research, Inc

                              • Parexel International Corporation

                              • ProScan Imaging

                              • Radiant Sage LLC

                              • Resonance Health

                              • WIRB-Copernicus Group

                              • Worldcare Clinical LLC


                          Specific to Clinical Trial Imaging Market
                          Need More Details On Market Players And Competitors?
                          Download Sample

                          Clinical Trial Imaging Market Report Snapshots

                          Clinical Trial Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)